Shay Capital’s Mural Oncology MURA Stock Holding History

Shay Capital’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,088	Closed	-$93.3K	–	569
2025 Q3	$93.3K	Buy	+45,088	New	+$96.9K	0.01%	383
2025 Q2	–	Sell	-113,519	Closed	-$143K	–	397
2025 Q1	$143K	Sell	113,519 -16,269	-13%	-$59.3K	0.02%	259
2024 Q4	$418K	Sell	129,788 -1,495	-1%	-$5.27K	0.06%	197
2024 Q3	$411K	Buy	131,283 +13,047	+11%	+$42.5K	0.06%	185
2024 Q2	$371K	Buy	118,236 +43,165	+57%	+$159K	0.05%	171
2024 Q1	$367K	Sell	75,071 -472	-0.6%	-$2.29K	0.06%	221
2023 Q4	$447K	Buy	+75,543	New	+$304K	0.09%	143

Shay Capital's MURA Position: Q4 2025 in Review

Shay Capital sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 45,088 shares — an estimated $93.3K sold.

Shay Capital first reported a position in MURA in Q4 2023 and held it in 7 quarters. The position peaked at $447K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Shay Capital reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Shay Capital sold 45,088 Mural Oncology shares in Q4 2025, an estimated $93.3K.
Shay Capital first reported a position in Mural Oncology in Q4 2023 and held it in 7 quarters.
Shay Capital's Mural Oncology position peaked at $447K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Shay Capital's 13F filing for Q4 2025, filed 17 Feb 2026.